Publication | Closed Access

The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway

Toll-like ReceptorsAutoimmune DiseaseHepatologyViral HepatitisLiver PhysiologyInnate Immune SystemImmunologyHepatitis BHepatitisToll-like ReceptorHumoral ResponseAutoimmunityMedicine